Education/Professional Experience
Education Experience
2011.9-2015.7 Ph.D. Gastroenterology, China Medical University, Liaoning China.
2003.9-2006.7 M.S. Internal Medicine, Dalian Medical University, Liaoning China.
1998.9-2003.7 B.S. Medicine, Yangzhou University, Jiangsu China.
Professional Experience
2016.6-2017.6 Visiting Associate Professor, Digestive Disease/Liver Center Yale University School of Medicine, USA
2015.1–present Associate Professor,Department of Gastroenterology First Affiliated Hospital of Dalian Medical University, China
2009.8-2014.12 Attending Physician,Department of Gastroenterology First Affiliated Hospital of Dalian Medical University, China
2006.7–2009.7 Resident Physician,Department of internal medicine First Affiliated Hospital of Dalian Medical University, China
Participation in the Academic Community
2015–present Youth committee member, Digestion Branch of Liaoning Medical Association.
2015-present Committee member, Group of IBD, Digestion Branch of Liaoning Medical Association.
Publication
1. Zhang J, Fang M, Wang Y, Mao J, Sun X. Intestinal pseudo-obstruction syndrome in systemic lupus erythematosus. Lupus, 20(12):1324-1328, 2011. (SCI)
2. Mao JW, He XM, Tang HY, Wang YD. Protective role of metalloproteinase inhibitor (AE-941) on ulcerative colitis in rats, World J Gastroenterol, 18(47), 7063-7069, 2012. (SCI)
3. Mao JW, Tang HY, Tan XY, Wang YD. Effect of Etiasa on the expression of matrix metalloproteinase-2 and tumor necrosis factor-α in a rat model of ulcerative colitis. Mol Med Rep, 6(5), 996-1000, 2012. (SCI)
4. Mao JW, Tang HY, Wang YD. Influence of Rosiglitazone on the Expression of PPARγ, NF-κB, and TNF-α in Rat Model of Ulcerative Colitis, Gastroenterol Res Pract, 845672, 2012. (SCI)
5. Tang H,Mao J, Gao L, Liu J, Wu T. Effect of antisense TIMP-1 cDNA on the expression of TIMP-1 and MMP-2 in lung tissue of pulmonary fibrosis induced by bleomycin. Mol Med Rep, 7(1), 149-153, 2013. (SCI)
6. Ji H, Tang H, Lin H, Mao J, Gao L, Liu J, Wu T. Rho/Rock cross-talks with transforming growth factor-β/Smad pathway participates in lung fibroblast-myofibroblast differentiation. Biomed Rep, 2(6):787-792, 2014.
7. Mao JW, Huang YS, Tang HY, Bi J, Liu YF, Wang YD. Flt3/Flt3L participates in the process of regulating dendritic cells and regulatory T cells in DSS-induced colitis. Gastroenterol Res Pract, 483578, 2014. (SCI)
8. Mao JW, Tang HY, Zhao T, Tan XY, Bi J, Wang BY, Wang YD. Intestinal mucosal barrier dysfunction participates in the progress of nonalcoholic fatty liver disease. Int J Clin Exp Pathol, 8(4), 3648-3658, 2015. (SCI)
Research Projects/Grants
1. Study on the effect of intestinal barrier in pathogenesis of NAFLD. Project of Liaoning Province Education Department, 2013.
Study on the impact of intestinal CCR9/CCL25 signaling pathway on gut immune barrier and its mechanism in NAFLD. Project of National Natural Science Foundation of China, 2015.
Admission Plan/Requirements
1-2foreignstudents/year.
The students should be interested in immune digestive diseases asinflammatory bowel disease, autoimmune liver disease and metabolic liver disease (NAFLD). Besides, the students should be good at speaking and writing English.
